Related Experiment Video
Updated: Apr 20, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
High sensitive C-reactive protein (hsCRP), cardiovascular events and mortality in the aged: a prospective 9-year
Marikka Kuoppamäki1, Marika Salminen2, Tero Vahlberg3
1Institute of Clinical Medicine, Family Medicine, University of Turku, Turku, Finland; Naantali Health Centre, Naantali, Finland.
Insights
High-sensitivity C-reactive protein (hsCRP) did not predict vascular disease events in older adults. While hsCRP predicted all-cause mortality, it did not add value beyond conventional risk factors.
Area of Science:
- Cardiology
- Gerontology
- Biomarkers
Background:
- High-sensitivity C-reactive protein (hsCRP) is a marker of inflammation.
- Its role in predicting vascular disease (VD) and mortality in older adults needs further investigation.
- Existing research on hsCRP and cardiovascular outcomes in the elderly is limited.
Purpose of the Study:
- To assess the clinical utility of hsCRP categorization in older adults.
- To determine if elevated hsCRP adds predictive value for cardiovascular morbidity and all-cause mortality beyond conventional risk factors.
- To investigate the association between hsCRP levels and vascular disease events in individuals aged 64 and above.
Main Methods:
- Prospective population-based study with a 9-year follow-up.
- Included 771 participants aged 64+ without prior VD and with C-reactive protein (CRP) <10 mg/L at baseline.
- Adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) were calculated for VD events and all-cause mortality based on hsCRP levels.
Main Results:
- hsCRP was not significantly associated with incident VD events after adjusting for age, gender, VD risk factors, or metabolic syndrome.
- hsCRP predicted all-cause mortality after adjustments for age and gender, but not independently of conventional risk factors.
- Participants with high hsCRP (3.0-9.9 mg/L) showed increased age- and gender-adjusted mortality and a trend towards higher risk factor-adjusted mortality compared to low-risk individuals (hsCRP <1 mg/L).
Conclusions:
- hsCRP categorization may not be clinically useful for predicting cardiovascular events in older adults.
- Elevated hsCRP levels do not appear to provide additive predictive value for vascular events beyond established risk factors.
- hsCRP's association with all-cause mortality in the elderly warrants further investigation but does not independently predict outcomes.
Objective:
The clinical utility of application of hsCRP categorization and the association of hsCRP with vascular disease (VD) events are less studied among the aged. This study investigated whether an elevated hsCRP has an additive effect on conventional vascular risk factors in predicting cardiovascular morbidity and all-cause mortality among the aged.
Methods And Results:
a prospective population-based study with a 9-year follow-up among persons aged ≥64 and without VD and C-reactive protein (CRP)<10mg/L at baseline (n=771). Adjusted hazard ratios (HRs) and their 95% confidence intervals (CIs) for VDs and all-cause mortality predicted by hsCRP level were estimated. During the follow-up, there were 151 major VD events, and 217 subjects died. After the adjustment for age and gender or risk factors related to VD events or a metabolic syndrome (MetS), hsCRP was not related to incident VD events (HR 1.14, 95% CI 0.96-1.35, p=.127 or 1.11, 0.94-1.32, p=.212, respectively). hsCRP predicted all-cause mortality after the adjustment for age and gender (1.18, 1.03-1.36, p=.020) and multiple factors (1.16, 1.00-1.33, p=.046) but not beyond conventional risk factors. High risk participants (hsCRP 3.0-9.9mg/L) had higher age and gender adjusted (1.50, 1.07-2.10, p=.018) and tended to have higher risk factor adjusted all-cause mortality (1.41, 1.00-2.00, p=.052) compared with low risk participants (hsCRP<1mg/L).
Conclusions:
hsCRP may not be useful in prediction of cardiovascular events.
Related Concept Videos
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Acute Coronary Syndrome III: Diagnostic Studies
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
